Back to Trials
NCT04880226NARecruitingAccepts Healthy Volunteers

A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation

Mayo Clinic

Start Date

8/30/2021

Completion Date

12/1/2027

Summary

The result of these studies will be used to improve patient care through assessment of new technology to determine whether it is beneficial (i.e. improving data acquisition speed or image quality) during iMRI procedures.

Detailed Description

This proposal includes evaluation of advanced MR imaging methods in the iMRI environment and will operate within the NSR guidelines for data acquisition established by the FDA/CDRH. The significant testing by vendor and Mayo staff prior to in vivo use, assure the safety of these studies and overall system stability. The result of these studies will be used to improve patient care through assessment of new technology to determine whether it is beneficial (i.e. improving data acquisition speed or image quality) during iMRI procedures.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Male or female. * Age ≥ 18 years. * Healthy volunteers or patients already scheduled for a MR-guided procedure. Exclusion Criteria: * Individuals 18 years of age. * Pregnant women.

Interventions

DEVICE

Magnetic Resonance Imaging (MRI)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Healthy

Locations

Mayo Clinic in Rochester

Rochester, Minnesota 55905

United States